News


First National Clinical Director for Women’s Health announced


The NHS has appointed Dr. Sue Mann, a Consultant and lead for women’s health in City and Hackney, North East London, as its first ever National Clinical Director for Women’s Health. In her new role, Dr. Mann will help implement the Women’s Health Strategy, alongside supporting the roll-out of women’s health hubs across England. She will also work on the development of a network of Women’s Health Champions, made up of senior leaders in every local care system to drive forward work to improve women’s health. Alongside extensive clinical and academic work, Dr. Mann spearheaded the development of Women’s Health Hubs in London City and Hackney, as well as implementing Virtual Group Consultations for common women’s health problems – both of which feature in the Women’s Health Strategy. Dr. Sue Mann commented: “Having spent my


career researching, treating, and developing policy and initiatives focused on women’s health, I have seen first hand the challenges many women face, as well as the progress that has been made through better understanding and awareness of conditions affecting women. “While our understanding and treatment of women’s healthcare has come a long way, we know there is still a lot more we need to do, and I am excited to be able to play a role in that, as the first National Clinical Director for Women’s Health, working with colleagues in the NHS to help shape important policy and improve the experiences of women’s health in England.” Ruth May, Chief Nursing Officer for England,


said: “The appointment of Dr. Sue Mann as National Clinical Director for Women’s Health will help us build on and further improve the work the NHS


NHS rolls out artificial pancreas in world first


Tens of thousands of children and adults living with type 1 diabetes across England are set to receive an ‘artificial pancreas’ in a world-first initiative being rolled out by the NHS. The device continually monitors a person’s blood glucose, then automatically adjusts the amount of insulin given to them through a pump. Local NHS systems will start identifying eligible people living with type 1 diabetes who health chiefs believe could benefit from the Hybrid Closed Loop system, sometimes called an ‘artificial pancreas’. There are currently 269,095 people living in England with type 1 diabetes. The technology will mean some people with type 1 diabetes will no longer need to inject themselves with insulin but rely on technology to


10 www.clinicalservicesjournal.com I May 2024


receive this life-saving medication. This can also help prevent life-threatening hypoglycaemic and hyperglycaemia attacks, which can lead to seizures, coma or even death for people living with type 1 diabetes. NHS England has provided local health systems with £2.5 million so they are ready to start identifying patients that can benefit. The mass roll-out of the artificial pancreas builds on a successful pilot of the technology by NHS England, which saw 835 adults and children with type 1 diabetes given devices to improve the management of their condition. The NHS in England currently spends around £10 billion a year – around 10% of its entire budget – on identifying and treating diabetes.


has been doing, making it as easy as possible for women to access advice and care for their specific needs, and significantly improve patient experience.” The new position has been announced alongside six other National Clinical Directors who have been recruited on three-year tenures or part-time secondments and will carry out their national role alongside their clinical duties. The new appointments include Dr. Lesley Kay, National Clinical Director for Musculoskeletal; Dr. Jeremy Isaacs, National Clinical Director for Dementia; and Dr. Thomas Downes, National Clinical Director for Older People and Integrated Personalised Care. Dr. Tony Avery, National Clinical Director for


Prescribing; Professor Ramani Moonesinghe, National Clinical Director for Critical and Perioperative Care; and Professor Matt Inada- Kim, National Clinical Director for Infection and Antimicrobial Resistance, have all been re- appointed to their NCD roles for another term.


Sponsored by


Patients with learning disibilities must have better health checks


Immediate action should be taken to make it easier for people with a learning disability to get the tailored health checks and preventive care they need to stay well, a think tank has warned. A new report from the Nuffield Trust highlights existing data showing a 20-year gap in median age at death between people with and without a learning disability and that two-in-five deaths of people with a learning disability in 2022 were classified as avoidable compared to one-in-five deaths for the general population. The analysis points to a 36-percentage point gap in the screening rate for cervical cancer; that young people aged 18 to 24 with a learning disability have double the prevalence of obesity (31% with a learning disability compared to 16% without); and that 22% of people with a learning disability are being treated with antidepressants compared to 11% of people without a learning disability. The authors show that people with learning disabilities are missing out on potentially life- saving preventive healthcare because services are disjointed, information and communication is not well-suited to them, and healthcare professionals lack knowledge about how to adapt services for people with a learning disability. View the full report at: https://tinyurl.com/


z6s8kkkx


Portakabin delivers solution for King George Hospital


Portakabin, a leader in modular construction, has handed over a brand-new, state-of-the-art decontamination suite, considerably upgrading and improving endoscopy patient care for Barking, Havering and Redbridge University Hospitals NHS Trust. The Trust required the building to be seamlessly integrated into its existing estate footprint, linking directly with the Juniper Endoscopy Unit (JEU) which consists of two procedure rooms and one recovery area. Decontamination facilities for the endoscopy unit were in need of major improvement and, with space at a premium on the site, a modular building from Portakabin allowed a new facility to be made available almost 70% quicker than a traditionally built solution.


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68